The prognostic value of secretogranin II and its impact on the immune microenvironment in patients with renal-cell carcinoma

Asian J Surg. 2023 Sep;46(9):4033-4035. doi: 10.1016/j.asjsur.2023.04.043. Epub 2023 Apr 27.

Authors

Lu-Xia Ye¹, Qing-Xin Yu¹, Deng-Xiong Li², Qiu-Peng Wang³

Affiliations

¹ Department of pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, Zhejiang Province, 317000, China.
² Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China. Electronic address: 1010441069@qq.com.
³ Department of pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, Zhejiang Province, 317000, China. Electronic address: wangqp@enzemed.com.

PMID: 37120376
DOI: 10.1016/j.asjsur.2023.04.043

No abstract available

Publication types

Letter

MeSH terms

Biomarkers, Tumor
Carcinoma, Renal Cell*
Humans
Kidney Neoplasms*
Prognosis
Protein Biosynthesis
Secretogranin II
Tumor Microenvironment

Substances

Secretogranin II
Biomarkers, Tumor